Literature DB >> 10087837

To what extent can the law control human cloning?

P G Wood.   

Abstract

This paper explores the legal ramifications of human reproductive cloning in response to 'Dolly'--the first animal cloned from an adult cell. No attempt is made to address the complex moral and ethical dilemmas that will inevitably be consequential on future successes in human reproductive cloning. Some of the potential benefits of cloning are briefly summarized but discussion is focused primarily on the current state of the law in the UK and some other European jurisdictions. Attempts to legislate on human cloning in the US, the emerging role of the EU and amendments to the European Convention on Human Rights are outlined. The potential problems likely to be encountered in the enforcement of any global treaties or international regulations are highlighted. It is argued that attempting to control human cloning by imposing legal prohibition is futile and a pragmatic solution to this impending problem is required forthwith.

Entities:  

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction; Legal Approach

Mesh:

Year:  1999        PMID: 10087837     DOI: 10.1177/002580249903900103

Source DB:  PubMed          Journal:  Med Sci Law        ISSN: 0025-8024            Impact factor:   1.266


  3 in total

Review 1.  What's in a name? Embryos, entities, and ANTities in the stem cell debate.

Authors:  K Devolder
Journal:  J Med Ethics       Date:  2006-01       Impact factor: 2.903

Review 2.  A comparison of assisted human reproduction (AHR) regulation in Ireland with other developed countries.

Authors:  Olivia McDermott; Lauraine Ronan; Mary Butler
Journal:  Reprod Health       Date:  2022-03-05       Impact factor: 3.223

3.  Systematic scoping review of the concept of 'genetic identity' and its relevance for germline modification.

Authors:  Floor M Goekoop; Carla G van El; Guy A M Widdershoven; Nadza Dzinalija; Martina C Cornel; Natalie Evans
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.